0001438133-24-000140.txt : 20240528 0001438133-24-000140.hdr.sgml : 20240528 20240528184426 ACCESSION NUMBER: 0001438133-24-000140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240523 FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novara Mark David CENTRAL INDEX KEY: 0002000342 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 24993537 MAIL ADDRESS: STREET 1: C/O TANDEM DIABETES CARE, INC. STREET 2: 12400 HIGH BLUFF DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 4 1 wk-form4_1716936259.xml FORM 4 X0508 4 2024-05-23 0 0001438133 TANDEM DIABETES CARE INC TNDM 0002000342 Novara Mark David 12400 HIGH BLUFF DRIVE SAN DIEGO CA 92130 0 1 0 0 EVP & CHIEF COMMERCIAL OFFICER 0 Restricted Stock Unit 2024-05-23 4 A 0 913 0 A Common Stock 913 913 D Performance Stock Unit 2024-05-23 4 A 0 913 0 A Common Stock 913 913 D Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. /s/ Rachel Malina, Attorney-in-Fact for Mark D. Novara 2024-05-28